Heart Disease News and Research

Latest Heart Disease News and Research

Dual antiplatelet therapy shows no benefit over aspirin after CABG in patients with acute coronary syndrome

Dual antiplatelet therapy (DAPT) was not more effective than aspirin alone for the prevention of major adverse cardiovascular events and increased major bleeding in patients with acute coronary syndrome (ACS) who underwent coronary artery bypass grafting (CABG), according to late-breaking research presented in a Hot Line session today at ESC Congress 20251 and simultaneously published in New England Journal of Medicine.

3 Sep 2025

Stopping oral anticoagulation reduces risk after successful atrial fibrillation ablation

Discontinuing oral anticoagulation (OAC) therapy resulted in a lower risk of a composite of stroke, systemic embolism or major bleeding than continuing OAC therapy in patients who had successful ablation for atrial fibrillation at least 12 months previously, according to results from a late-breaking trial presented in a Hot Line session today at ESC Congress 2025 and simultaneously published in The Journal of the American Medical Association.

3 Sep 2025

Reconditioned pacemakers show comparable infection rates to new devices

Procedure-related infection rates were similar with reconditioned and new pacemakers, according to late-breaking research presented in a Hot Line session today at ESC Congress 2025.

3 Sep 2025

Sacubitril/valsartan shows benefit over enalapril in heart failure caused by Chagas disease

In patients with heart failure (HF) caused by Chagas disease, sacubitril/valsartan was superior to enalapril for the composite primary endpoint, predominantly driven by a significant reduction in N-terminal pro-B-type natriuretic peptide (NT-proBNP), according to late-breaking research presented in a Hot Line session today at ESC Congress 2025.

3 Sep 2025

Evolocumab fails to reduce vein graft disease after coronary artery bypass surgery

After coronary artery bypass grafting (CABG), evolocumab did not reduce saphenous vein graft disease rates at 2 years compared with placebo, according to late-breaking research presented in a Hot Line session today at ESC Congress 2025 and simultaneously published in Lancet.

3 Sep 2025

No clear benefit from surgical left atrial appendage occlusion in non-AF patients after valve surgery

No benefit in terms of prevention of ischemic stroke, transient ischemic attack and cardiovascular mortality after 1 year was observed when surgical left atrial appendage occlusion was performed in high-risk non-atrial fibrillation patients after valvular surgery, according to late-breaking research presented in a Hot Line session today at ESC Congress 2025.

3 Sep 2025

Long-term benzodiazepine use linked to poor sleep quality in older adults

Long-term use of benzodiazepine and related drugs has been linked to poorer quality sleep in older adults with insomnia.

3 Sep 2025

Flooding from Hurricane Sandy raises heart disease risk years later

Although the material damage from 2012's Hurricane Sandy may have been repaired, the storm left a lasting impact on cardiovascular health, according to new findings from Weill Cornell Medicine and New York University researchers.

3 Sep 2025

Researchers uncover a promising new therapeutic target for Barth syndrome

Researchers at The Hospital for Sick Children (SickKids) have uncovered a promising new therapeutic target for Barth syndrome, a rare genetic condition with no current cure.

3 Sep 2025

Intravenous cangrelor provides rapid platelet inhibition in cardiogenic shock

Compared with crushed ticagrelor, intravenous cangrelor provided immediate, effective platelet inhibition, with no increase in major bleeding and lower mortality rates in patients with acute myocardial infarction and cardiogenic shock, according to late-breaking research presented in a Hot Line session today at ESC Congress 2025.

3 Sep 2025

Home-based hypertension care improves blood pressure control in rural South Africa

Home-based hypertension care led to reductions in systolic blood pressure and improvements in hypertension control in South Africa, according to late-breaking research presented in a Hot Line session today at ESC Congress 2025 and simultaneously published in the New England Journal of Medicine.

3 Sep 2025

Early aspirin discontinuation safe after complete revascularization in acute MI

Among low-risk patients with acute MI who underwent early complete revascularization and received one month of dual antiplatelet therapy (DAPT), P2Y12 inhibitor monotherapy was noninferior to continued DAPT for adverse cardiovascular and cerebrovascular events, while reducing bleeding risk.

3 Sep 2025

Novel ablation approach improves outcomes in patients with persistent atrial fibrillation

Adding digital twin-guided ablation to a standard ablation technique improved outcomes in patients with persistent atrial fibrillation (AF), according to late-breaking research presented in a Hot Line session today at ESC Congress 2025.

3 Sep 2025

Ablation methods equally effective for drug-resistant paroxysmal atrial fibrillation

Pulsed field ablation did not have superior efficacy to radiofrequency ablation in patients with drug-resistant paroxysmal (intermittent) atrial fibrillation, according to results from a late-breaking trial presented in a Hot Line session today at ESC Congress 2025.

3 Sep 2025

How effective is the RSV vaccine for older adults?

A single dose of the RSV vaccine offers 58% protection against hospitalization in older adults, but effectiveness varies in immunocompromised individuals.

3 Sep 2025

Qureight appoints Craig Rhodes as Head of Partnerships to lead on pharma relationship management

Qureight, a techbio company advancing the understanding of lung and heart disease through application of its AI-powered imaging and clinical data curation platform, today announced the appointment of Craig Rhodes as Head of Partnerships to lead strategic engagements with pharmaceutical organizations, in line with Qureight’s revenue growth targets.

From Qureight 3 Sep 2025

Study reveals how type 2 diabetes directly alters the heart’s structure and energy systems

A new study from the University of Sydney has revealed how type 2 diabetes directly alters the heart’s structure and energy systems, offering vital insights into why people with diabetes are at greater risk of heart failure.

2 Sep 2025

Household WiFi devices show potential for nonintrusive health monitoring

Heart rate is one of the most basic and important indicators of health, providing a snapshot into a person's physical activity, stress and anxiety, hydration level, and more.

2 Sep 2025

Faster progression to severe diabetes observed in people with learning disabilities

People with learning disabilities progress faster to severe type 2 diabetes and are at greater risk of dying from their condition than people without these disabilities, suggests research published in the open access journal BMJ Open Diabetes Research & Control.

2 Sep 2025

AI scans arteries and predicts risk after heart attack better than traditional review

Researchers found that AI applied to OCT imaging can standardize detection of thin-cap fibroatheroma (TCFA) and identify post–heart attack patients at higher two-year risk. Whole-segment AI analysis outperformed lesion-focused human review, offering stronger prognostic value and reassurance for low-risk patients.

2 Sep 2025

Previous
1
...
9
10
11
12
13
14
15
...
2956
Next

Heart Disease News and Research

Latest Heart Disease News and Research

Dual antiplatelet therapy shows no benefit over aspirin after CABG in patients with acute coronary syndrome

Stopping oral anticoagulation reduces risk after successful atrial fibrillation ablation

Reconditioned pacemakers show comparable infection rates to new devices

Sacubitril/valsartan shows benefit over enalapril in heart failure caused by Chagas disease

Evolocumab fails to reduce vein graft disease after coronary artery bypass surgery

No clear benefit from surgical left atrial appendage occlusion in non-AF patients after valve surgery

Long-term benzodiazepine use linked to poor sleep quality in older adults

Flooding from Hurricane Sandy raises heart disease risk years later

Researchers uncover a promising new therapeutic target for Barth syndrome

Intravenous cangrelor provides rapid platelet inhibition in cardiogenic shock

Home-based hypertension care improves blood pressure control in rural South Africa

Early aspirin discontinuation safe after complete revascularization in acute MI

Novel ablation approach improves outcomes in patients with persistent atrial fibrillation

Ablation methods equally effective for drug-resistant paroxysmal atrial fibrillation

How effective is the RSV vaccine for older adults?

Qureight appoints Craig Rhodes as Head of Partnerships to lead on pharma relationship management

Study reveals how type 2 diabetes directly alters the heart’s structure and energy systems

Household WiFi devices show potential for nonintrusive health monitoring

Faster progression to severe diabetes observed in people with learning disabilities

AI scans arteries and predicts risk after heart attack better than traditional review

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Heart Disease News and Research

Latest Heart Disease News and Research

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Newsletters you may be interested in